Overview

Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of OPTIVEĀ® MD for ocular surface integrity in symptomatic dry eye condition in absence of obvious eye-lid inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Glycerol
Hyaluronic Acid